Back to search

Belgium· BE-AMP-SAM128703-00

Erythrocine 250 mg/5 ml

A erythromycin product containing erythromycin ethylsuccinate, registered in Belgium by Amdipharm. The same ATC class is registered in 13 of our 19 countries.

ATC J01FA01

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedErythrocine 250 mg/5 mlATCJ01FA01REGISTER NO.BE-AMP-SAM128703-00PACKS LISTED2CHECKEDSeptember 26, 2026

Where it is registered

Erythromycin is registered in 13 of 19 countries.

Countries holding a registration under ATC J01FA01 (erythromycin), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 6 of them publish a price we can compare per daily dose

Erythromycin · ATC J01FA01

13 / 19 countries

  • Belgiumprice
  • Canada
  • Denmark
  • Finlandprice
  • Germany
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Erythromycin Ethylsuccinate
Manufacturer
Amdipharm
Country
Belgium (BE)
ATC code
J01FA01
ATC class
Erythromycin
Defined daily dose
1 g, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

1 priced
  • be_apb
    0842112
    EUR 10.75
  • be_apb
    0727917

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

1011 interactions on record for erythromycin.

Graded by severity as the source publishes them — 216 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Erythromycin · interactions on record

1011 records

  • 216 severe
  • 424 moderate
  • 70 minor
  • 227 info

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • NaloxegolA06AH03severe

74 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Erythromycin in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All erythromycin products

Authorised across Europe · EMA

The same active substance is authorised in 10 EEA countries. Names it is sold under:

  • Germany · Erythrocin Neo
  • Denmark · Abboticin, Abboticin Novum
  • Spain · Eritromicina Normon, Pantomicina
  • France · Ery Enfants, Erythrocine
  • United Kingdom (Northern Ireland) · Erythromycin, Erythromycin Amdipharm Uk
  • Ireland · Erythroped, Erythroped Pi
  • Luxembourg · Erythrocine, Erythroforte
  • Malta · Primacine
  • Norway · Abboticin Es
  • Portugal · E.S.E. 500, Eritrocina

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f7edce34-a38a-429e-826e-5780c9ae505b
GET /v1/drugs/f7edce34-a38a-429e-826e-5780c9ae505b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Granules for oral suspension",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Erythrocine 250 mg/5 ml",
  "name_fr": "Erythrocine 250 mg/5 ml",
  "name_nl": "Erythrocine 250 mg/5 ml",
  "amp_code": "SAM128703-00",
  "strengths": [
    "133.8000",
    "105.2000",
    "1.6000"
  ],
  "pack_count": 1,
  "substances": [
    "Erythromycin Ethylsuccinate",
    "Erythromycin",
    "Saccharin Sodium"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Erythromycin",
  "authorisation_numbers": [
    "BE128703"
  ]
}

See everything about erythromycin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.